MDCX vs AMRN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 15, 2026
MDCX
AMRN
Investment Advisor Scores
AMRN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MDCX | AMRN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 500 | Tie |
| PEG Ratio | 0 | 0.8093 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | -20.4% | MDCX |
| Earnings Growth | 0.0% | -94.2% | MDCX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 63.1/100 | 37.2/100 | MDCX |
| Profit Margin | 0.0% | -10.9% | MDCX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | MDCX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MDCX
MarkupPrice above SMA50, rising 50-day trend (144.4% over 20 days), RSI 53
AMRN
MarkdownPrice below a falling SMA50 (slope -6.5%), weak momentum, RSI 37
Fundamentals Snapshot
| Metric | MDCX | AMRN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.1 | -189.7 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.2% |
| Gross Margin | — | 0.4% |
| Operating Margin | 0.0% | -0.1% |
| EPS | -76.65 | -0.80 |
| Dividend Yield | — | — |